Fengtian Xue

Dr Fengtian Xue have a broad training in organic synthesis, medicinal chemistry, and drug discovery with specific training and expertise in early-stage development of small molecule therapeutics. Dr Xue received his PhD at Brown University in 2007 and continued his postdoctoral training in the Silverman Laboratory between 2007 and 2009 at Northwestern University. After a two-year teaching experience at University of Louisiana at Lafayette, in 2011 Dr Xue started independent research lab at University of Maryland Baltimore, where he is currently an Associate Professor in the Department of Pharmaceutical Sciences. Dr Xue's graduate and postdoctoral studies focus on design, synthesis and biological evaluations of small molecule inhibitors for disease-related enzymes (e.g., serine protease plasmin and neuronal nitric oxide synthase). His studies identified novel drug candidates for metastasis cancer and neurodegenerative diseases. During this period, Dr Xue published as first author in 15 research articles. In addition, he is also an inventor of seven patent applications. Dr Xue has been leading his independent lab for seven years. The Xue Laboratory has a broad interest in the development of small molecule therapeutics for important human diseases including bacterial / parasitic infections, cancer, metabolic disorders, and neurodegenerative diseases, with over 50 research articles and seven patent applications.